对非类固醇葡萄糖皮质体受体激动剂非类固醇葡萄糖皮质体受体激动剂的影响
Zhou Xu1, Zhongyuan Wang1, Xiaona Shi1
1WuXi AppTec, Tianjin Economic-Technological Development Area TEDA 168 Nanhai Road, TJS 300457 China xu_zhou@wuxiapptec.com.
研究人员研究了一种非类固醇葡萄糖皮质体受体调节器GSK866.6的稳定基体. 他们确定了具有独特立体化学的强效化合物,这对药物开发至关重要.
科学领域:
- 药用化学 医学化学
- 计算化学计算化学
- 分子药理学分子药理学
背景情况:
- 葡萄糖皮质体受体 (GR) 的非类固醇调节剂是关键的治疗点.
- 了解候选药物的立体化学对于优化疗效至关重要.
- 在药物设计中,阿特罗皮索默症带来了独特的挑战和机遇.
研究的目的:
- 通过计算预测和实验验证新型非类固醇GR调节器GSK866.6的稳定亚特罗皮索默.
- 评估已识别的形体的差异性生物活性.
- 为了确定最强大的亚特罗皮索默的绝对立体化学.
主要方法:
- 一个虚拟图书馆的列表替代的酸类似物.
- 使用Spartan'20进行扭矩角度扫描,以预测形体形成的能量障碍.
- 预测的形体的合成和表征.
- 葡萄糖皮质醇受体细胞测定用于疗效评估.
- 使用公共GR晶体结构 (PDB ID: 3E7C) 的分子对接研究.
主要成果:
- 计算分析成功地预测了几个类型的稳定体.
- 合成证实了13和14 (13a,13b,14a,14b) 化合物中稳定的体的存在.
- 在每一对中的亚特罗皮索默之间观察到强度的显著差异.
- 最强效的化合物 (13a和14b) 的绝对立体化学分别被分配为 (Ra) 和 (Sa).
结论:
- 这项研究成功地鉴定和表征了非类固醇GR调节器的稳定亚特罗皮索默.
- 亚特罗皮索默之间的功率差异突显了立体化学在GR调制中的重要性.
- 这些发现为开发具有改善治疗配置的立体化学定义GR调节器提供了基础.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
相关概念视频
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
The Two-State Receptor Model
The binding affinity of a drug determines its interaction with...
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Drug-Receptor Interaction: Antagonist
Antagonists can be classified as competitive or noncompetitive based on their...
GPCRs Regulate Adenylyl Cylase Activity
